within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01C_CardiacStimulantsExclCardiacGlycosides.C01CA07_Dobutamine;

model Dobutamine
  extends Pharmacolibrary.Drugs.ATC.C.C01CA07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01CA07</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dobutamine is a synthetic catecholamine and direct-acting inotropic agent primarily used in the short-term treatment of cardiac decompensation due to depressed contractility resulting from organic heart disease or cardiac surgical procedures. It acts mainly through stimulation of beta-1 adrenergic receptors. Dobutamine is approved for use in acute heart failure and is administered intravenously in clinical settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers receiving short-term intravenous infusion.</p><h4>References</h4><ol><li><p>Lehtonen, LA, et al., &amp; Pentikäinen, PJ (2004). Pharmacokinetics and pharmacodynamics of intravenous inotropic agents. <i>Clinical pharmacokinetics</i> 43(3) 187–203. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200443030-00003&quot;>10.2165/00003088-200443030-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14871156/&quot;>https://pubmed.ncbi.nlm.nih.gov/14871156</a></p></li><li><p>Habib, DM, et al., &amp; Minegar, C (1992). Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. <i>Critical care medicine</i> 20(5) 601–608. DOI:<a href=&quot;https://doi.org/10.1097/00003246-199205000-00010&quot;>10.1097/00003246-199205000-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1572184/&quot;>https://pubmed.ncbi.nlm.nih.gov/1572184</a></p></li><li><p>Kates, RE, &amp; Leier, CV (1978). Dobutamine pharmacokinetics in severe heart failure. <i>Clinical pharmacology and therapeutics</i> 24(5) 537–541. DOI:<a href=&quot;https://doi.org/10.1002/cpt1978245537&quot;>10.1002/cpt1978245537</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/699477/&quot;>https://pubmed.ncbi.nlm.nih.gov/699477</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Dobutamine;
